期刊文献+

罗格列酮对环孢素A所致大鼠成纤维细胞肾毒性的保护作用 被引量:8

Protective effect of rosiglitazone on cyclosporine A-induced nephrotoxicity in rat NRK cells
原文传递
导出
摘要 目的观察免疫抑制剂环孢素A(CsA)对大鼠肾脏成纤维细胞(NRK)增生及细胞因子分泌的影响以及罗格列酮的干预作用,初步探讨罗格列酮对环孢素A肾毒性的保护作用。方法体外培养大鼠肾脏成纤维细胞。四甲基偶氮唑盐(MTT)比色法测定CsA及罗格列酮对细胞增生的影响。RT-PCR检测过氧化物酶体增殖物激活受体(PPAR)γ、TGF—β1mRNA水平。western印迹检测PPARγ、AT1受体、磷酸化细胞外信号调节激酶(p-ERK)及FN蛋白表达。酶联免疫吸附(ELISA)测定细胞培养上清液中TGF-β1的分泌。结果CsA可明显抑制NRK细胞增生,且呈剂量和时间依赖性(P<0.05)。罗格列酮与CsA合用后,对细胞增殖的抑制作用更明显(P<0.01)。CsA刺激NRK细胞PPARγ、TGF—β1、AT1受体及FN的产生(P<0.05),罗格列酮可下调这些改变(P<0.05)。结论罗格列酮可减轻CsA所致的NRK细胞毒性。 Objective To investigate the protective effects of rosiglitazone (RSG) on normal rat kidney cells (NRK) damaged by cyclosporine A(CsA). Methods The NRK cells were cultured with CsA or with CsA plus rosiglitazone. The cellular proliferation was determined by MTT colorimetry. The mRNA expression of TGF-β1 and PPARγ was detected by RT-RCR. Protein levels of PPARγ, p-ERK,FN and AT1R were examined by Western blotting. The level of TGF-β1 in the supernatants was measured by enzyme-linked immunosorbant assay (ELISA). Results CsA inhibited the proliferation of NRK cells in dose and time dependent manner (P < 0.05), treatment with RSG accelerated the suppression of NRK resulted from CsA (P < 0.05). CsA stimulated the expression of PPARγ, TGF-β1, p-ERK, FN and AT1R compared with control group (P < 0.05), and such up-regulating expression could be decreased by rosilitazone (P<0.05). Conclusion Rosiglitazone may relieve the nephrotoxicily on NRK cells resulted from CsA.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2005年第5期282-285,共4页 Chinese Journal of Nephrology
  • 相关文献

参考文献16

  • 1刘章锁,牛红心,程根阳,李军辉,宋洁.罗格列酮对糖尿病大鼠肾保护机制的研究[J].中华肾脏病杂志,2004,20(2):109-112. 被引量:35
  • 2Galli A, Crabb DW, Ceni E, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology, 2002,122:1924-1940.
  • 3孙正达,陈靖,丁爽爽,邱长斌,杨海春,朱蔚钰,马骥,顾勇,林善锬.波生坦和依那普利对糖尿病大鼠肾脏中过氧化物酶体增殖物激活剂受体γ途径的作用[J].中华肾脏病杂志,2003,19(1):43-48. 被引量:11
  • 4Ruiz-Ortega M, Egido J. Angiotensin Ⅱ modulates cell growthrelated events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int, 1997, 52:1497-1510.
  • 5Pichler RH, Franceshini N, Young BA, et al. Pathogenesis of cyclosporine nephrophthy: Roles of angiotensin Ⅱ and osteopontin.J Am Soc Nephrol, 1995,6:1186-1196.
  • 6Dartsch PC, Schmid H. Human fibroblasts in culture exhibit a low sensitivity against cyclosporine A treatment. Ren Physiol Biochem, 1994, 17:267-277.
  • 7Parameswaran N, Hall CS, bomberger JM, et al. Negative growth effects of ciglitazone on kidney interstitial fibroblasts:role of PPAR-gamma. Kidney Blood Press Res, 2003, 26:2-9.
  • 8Wolf G, Neilson EG. Angiotensin Ⅱ induces cellular hypertrophy in culture murine proximal tutular cells. Am J Physiol, 1990,259: F768-F777.
  • 9张国华,张训,侯凡凡,王力.肾素血管紧张素系统激活在环孢霉素A肾病中的作用[J].中国危重病急救医学,2003,15(12):754-757. 被引量:2
  • 10Hamaguchi A, Kim S, Yano M, et al. Activation of glomerular mitogen-activated protein kinases in angiotensin Ⅱ-mediated hypertension. J Am Soc Nephrol, 1998, 9:372-380.

二级参考文献27

  • 1Nicholas SB, Kawano Y, Wakino S, et al. Expression and function of peroxisome proliferators-activated receptor-γin mesangial cells.Hypertension, 2001,37 (Pt 2 ): 722.
  • 2Tsuchiya T, Shimizu H, Shimomura K, et al. Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells. Am J Nephrol, 2003, 23: 222-228.
  • 3Asano T, Wakisaka M, Yoshinnari M, et al. Peroxisome proliferator activated receptor gamma 1 (PPARγ1) expresses in rat messeagial cells and PPARγ1 agonists modulate its differentiation.Biochim Biophys Acta, 2000; 1497 ( 1 ): 148-154.
  • 4Ricote M, Li AC, Willson TM, et al. The peroxisome proliferators-activated receptor-γ is a negative regulator of macrophage activation. Nature, 1998, 391: 79-82.
  • 5Su CG, Wen XM, Bailey ST, et al. A novel therapy for colitis utilizing PPAR ligands to inhibit the epithelial inflammatory response. J Clin Invest, 1999, 104: 383-389.
  • 6奚涛.受体的调节.见:吴梧桐,主编.现代生化药学.第1版.北京:中国医药科技出版社,2002.212-215.
  • 7Parameswaran N, Hall CS, Bomberger JM, et al. Negative growth effects of ciglitazone on kidney interstitial fibroblasts: role of PPAR-gamma. Kidney Blood Press Res, 2003; 26: 2-9.
  • 8RE Buckingham, KA A1-Barazanji, CD Toseland, et al.Peroxisome proliferator activated receptor agonist, rosiglitazone,protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes, 1998,47: 1326-1334.
  • 9Ma LJ, Marcantpni C, Linton MF, et al. Peroxisome proliferator activated receptor-γagonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int, 2001,59: 1899-1910.
  • 10Iwashima Y, Eto M, Horiuchi S, et al. Advanced glycation end product-induced peroxisome proliferators-activated receptor γgene expression in the cultured mesangial cells. Biochem Biophy Res Commun, 1999, 264: 441.

共引文献45

同被引文献115

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部